Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Location contact
David Mischoulon, MD, PhD
CONTACT
Maren B Nyer, PhD
CONTACT
NCT Number: NCT07082998
This project explores whether heated yoga, sauna, and a mindfulness app reduce depressive symptoms
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Location status: Recruiting
David Mischoulon, MD, PhD
CONTACT
Maren B Nyer, PhD
CONTACT
This is a parallel group study design. The investigators plan to enroll 120 adults who have at least moderate depression and will be randomized in an equal allocation ratio (i.e., 1:1:1) across three groups: heated yoga vs. sauna vs. a mindfulness app. The interventions will be provided over a 12-week period and assessments will occur at baseline (Week 0), mid-intervention (Weeks 4 & 8), post-intervention (Week 12, primary outcome), and at a 4-week (Week 16). Then participants enter an optional 1-month choice intervention period with a post-assessment (Week 20).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Subject Characteristics
Inclusion criteria
Exclusion criteria
12-weeks of twice weekly 90-min heated yoga classes in the community
12-weeks of twice weekly 40-min sauna sessions in the community
12-weeks of 80-mins a week of a mindfulness app
Time frame: Weeks 0, 4, 8, 12, 26, 20
The PHQ- 9 is a 9-item self-report questionnaire that is widely used to assess depression symptom severity. Score range from 0 to 27, with a high score (20-27) indicating severe depression.
Time frame: Weeks 0, 4, 8, 12, 16, 20
A 15-item self-report instrument that measures mindfulness; derived from factor analytic study of five independent mindfulness questionnaires. Total scores range from 15 to 75, with higher scores indicating greater utilization of mindfulness techniques.
Time frame: Weeks 0, 4, 8, 12, 16, 20
A 22-item questionnaire that assess rumination, with scores range from 22 to 88. Lower scores reflect less frequent engagement in ruminative thought patterns.
Time frame: Weeks 0, 4, 8, 12, 16, 20
A 5-item self-report questionnaire with positively-worded statements related to general mood over the prior two weeks. WHO-5 has shown strong construct validity as a measure of general quality of life, and is sensitive to change. Scores range from 0 to 25, with higher scores reflecting overall well-being.
Time frame: Weeks 0, 4, 8, 12, 16, 20
PROMIS-29 is used to assess psychometric properties under the domains of physical function, fatigue, pain interference, depressive symptoms, anxiety, social functioning, sleep disturbance using four items per domain. This measure uses a T-score metric for scoring, typically ranging from 20 to 80, with a lower T-score (below 50) indicating less severity of symptoms.
Time frame: Week 12
Used to evaluate participants' thoughts about the study and collect information on their experience. The data collected is qualitative.
Contact information is provided by the study sponsor or research team.
Maren B Nyer, PhD
CONTACT
Sophie Gower
CONTACT
Massachusetts General Hospital
Other
Acronym: SHINE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06793397
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT06675240
Anxiety Disorders, Behavior
La Jolla, California, United States
View Trial DetailsNCT07212075
Anorexia Nervosa, Anxiety Disorder (Panic Disorder or GAD)
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT07085143
Behavior, Behavioral Symptoms
Shanghai, Shanghai Municipality, China
View Trial Details